Assessment of Screening Modalities for Gynecologic Cancers
Public ClinicalTrials.gov record NCT00879840. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Background: * Endometrial and ovarian cancers are, respectively, the fourth and eighth most common cancers among women in the United States. Although some routine Pap tests may detect the presence of cancer cells, there are no convincing early detection approaches for either cancer. Better methods of detection are needed. * Two possible methods for cancer detection involve samples taken with a tampon or a special kind of brush, called a Tao brush. Researchers would like to know more about how well these methods work. Objectives: * To assess the quality of DNA collected by the tampon and Tao brush sampling methods. * To detect genetic markers in collected DNA and determine if these markers are related to an individual s cancer status. Eligibility: * Women age 45 years and older with confirmed or suspected endometrial or ovarian cancer, who will be having surgery. * A control group of postmenopausal women having surgery for benign gynecological conditions will be included. Design: * Shortly before hysterectomy or more extensive procedures to treat either cancer or the benign condition: * A tampon will be inserted into the vagina to collect cell samples, and removed after 30 minutes. * After the tampon is removed, the cervix will be swabbed with the Tao brush to collect cell samples. * Following the hysterectomy, samples of healthy and cancerous tissue will be taken, and tested by researchers.
Study identification
- NCT ID
- NCT00879840
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 118 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 50 Years to 120 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 8, 2009
- Primary completion
- Sep 1, 2020
- Completion
- Nov 15, 2020
- Last update posted
- Nov 16, 2020
2009 – 2020
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic, Rochester | Rochester | Minnesota | 55905 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00879840, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 16, 2020 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00879840 live on ClinicalTrials.gov.